Literature DB >> 14758116

Severe acute respiratory syndrome: public health response and clinical practice update for an emerging disease.

Natalie Keeler1, Jairam Lingappa.   

Abstract

PURPOSE OF REVIEW: Severe acute respiratory syndrome is an emerging infectious disease with high morbidity and mortality and potential for global spread. This review highlights the salient points of the 2002-2003 outbreak to help clinicians with early recognition, treatment, disease control, and prevention. RECENT
FINDINGS: Severe acute respiratory syndrome is a respiratory illness caused by a novel coronavirus, severe acute respiratory syndrome-coronavirus. The disease was first recognized in Asia in February 2003 and, over the next several months, spread to more than two dozen countries in North and South America, Europe, and Asia. The disease is characterized by fever with symptomatic and radiographic evidence of pneumonia.
SUMMARY: Because diagnosis cannot be established by clinical findings alone, epidemiologic findings (including history of travel to affected areas, close contact with other case patients, or linkage to clusters of unexplained pneumonia) play a critical role in the diagnostic evaluation. Infection control procedures (including droplet and airborne precautions) are critical for preventing transmission.

Entities:  

Mesh:

Year:  2004        PMID: 14758116     DOI: 10.1097/00008480-200402000-00012

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  1 in total

1.  SARS-CoV infection in a restaurant from palm civet.

Authors:  Ming Wang; Meiying Yan; Huifang Xu; Weili Liang; Biao Kan; Bojian Zheng; Honglin Chen; Han Zheng; Yanmei Xu; Enmin Zhang; Hongxia Wang; Jingrong Ye; Guichang Li; Machao Li; Zhigang Cui; Yu-Fei Liu; Rong-Tong Guo; Xiao-Ning Liu; Liu-Hua Zhan; Duan-Hua Zhou; Ailan Zhao; Rong Hai; Dongzhen Yu; Yi Guan; Jianguo Xu
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.